The 2024 Pharmacy Benefit Manager Customer Satisfaction Report published by Pharmaceutical Strategies Group ("PSG") disclosed ...

SAN DIEGO - MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company, announced that it is continuing to evaluate strategic alternatives to maximize shareholder value, including ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

Meanwhile, MEI Pharma has enlisted Oppenheimer for a strategic review to optimize shareholder value. This comes after the pharmaceutical company announced significant leadership changes and strategic ...

We recently compiled a list of the 10 Best Japanese Stocks To Buy Now. In this article, we are going to take a look at where ...

Despite its government spending more than any other on health care both per capita and as a percentage of GDP, spending over $4.5 trillion in 2022, the United States has the lowest life expectancy at ...

In our digital and social media themed month, Rodica Ceslov highlights how pharma is exploring the use ... With forward thinking and a solid marketing strategy in place, companies can realize ...

nbsp, Gilead’s leap from 10th position overall in 2011 to 2nd in 2012 is largely due to a change in respondents ... suggest three important strategic pointers for pharma: Companies need ...

NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently concluded its 2024 Special Meeting of Stockholders with significant ...